HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short communication: a technique for delivering carbogen with high dose rate intraluminal brachytherapy in carcinoma of the oesophagus; early results and toxicity.

Abstract
A technique to deliver carbogen with high dose rate afterloading therapy to the oesophagus is described. Treatment is given using a standard high dose rate (HDR) afterloading catheter which is passed through the tumour-bearing area of the oesophagus within a nasogastric tube. In order to achieve a gas-tight seal, a standard "oxygen" mask used for delivery of carbogen is modified to incorporate the nasogastric tube allowing the treatment catheter to pass through the mask and be connected to the afterloading machine. The technique has proven to be feasible and well tolerated during treatment in four patients treated in this way. Severe acute radiation toxicity, possibly attributable to the carbogen, has been encountered in these patients receiving 1500 cGy at 1 cm via the HDR catheter after 4050 cGy in 27 fractions in 9 days using CHART external beam. Modifications to the radiation scheduling is recommended to enable carbogen to be incorporated in this way.
AuthorsP J Hoskin, M E Powell, M I Saunders
JournalThe British journal of radiology (Br J Radiol) Vol. 69 Issue 827 Pg. 1049-51 (Nov 1996) ISSN: 0007-1285 [Print] England
PMID8958025 (Publication Type: Journal Article)
Chemical References
  • Radiation-Sensitizing Agents
  • Carbon Dioxide
  • carbogen
  • Oxygen
Topics
  • Brachytherapy (adverse effects, instrumentation, methods)
  • Carbon Dioxide (administration & dosage)
  • Equipment Design
  • Esophageal Neoplasms (radiotherapy)
  • Humans
  • Intubation, Gastrointestinal
  • Masks
  • Oxygen (administration & dosage)
  • Radiation-Sensitizing Agents (administration & dosage)
  • Radiotherapy Dosage

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: